Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Jan Frisell"'
Autor:
Axel Frisell, Hannah Coudé Adam, Ann-Charlot Docherty Skogh, Jana de Boniface, Ira Oikonomou, Jan Frisell, Helena Sackey, Yihang Liu
Publikováno v:
British Journal of Surgery. 108:1474-1482
Current evidence for the effects of radiotherapy (RT) on implant-based immediate breast reconstruction (IBR) is limited by short follow-up and lack of patient-reported outcomes (PROs). It is central to integrate long-term comprehensive outcome data i
Autor:
Jakob Lagergren, Pankaj G. Roy, Fredrik Lohmander, Jan Frisell, Hemming Johansson, Yvonne Brandberg
Publikováno v:
BJS Open
BJS Open, Vol 4, Iss 5, Pp 811-820 (2020)
BJS Open, Vol 4, Iss 5, Pp 811-820 (2020)
Background Acellular dermal matrix (ADM) in implant‐based breast reconstructions (IBBRs) aims to improve cosmetic outcomes. Six‐month data are presented from a randomized trial evaluating whether IBBR with ADM provides higher health‐related qua
Publikováno v:
The British journal of surgery. 108(9)
Background Completion axillary lymph node dissection has been abandoned widely among patients with breast cancer and sentinel lymph node micrometastases, based on evidence from prospective RCTs. Inclusion in these trials has been subject to selection
Autor:
Thorsten Kühn, Steffi Hartmann, Angrit Stachs, Bernd Gerber, J. de Boniface, I Wiklander-Bråkenhielm, Johannes Stubert, Toralf Reimer, Jan Frisell, A Winckelmann
Publikováno v:
The British journal of surgery. 108(3)
Background Several techniques for targeted lymph node biopsy in patients with node-positive breast cancer receiving primary systemic therapy are in use, each with their inherent advantages and disadvantages. The aim of the TATTOO trial was to evaluat
Publikováno v:
The British journal of surgery. 108(5)
Background This follow-up analysis of a Swedish prospective multicentre trial had the primary aim to determine invasive disease-free (IDFS), breast cancer-specific (BCSS) and overall survival (OS) rates, and their association with axillary staging re
Publikováno v:
Breast Cancer Research and Treatment. 171:359-369
The clinical significance of lymph node micrometastases and isolated tumor cells (ITCs) in breast cancer is still controversial. After a median follow-up of 52 months, a report from the Swedish Multicenter Cohort Study presented a worse cancer-specif
Autor:
Fuat Celebioglu, L. Zetterlund, Jan Frisell, Athanasios Zouzos, Thomas Hatschek, Rimma Axelsson, Jana de Boniface
Publikováno v:
Breast Cancer Research and Treatment
Purpose Patients with clinically node-positive breast cancer planned for neoadjuvant systemic therapy (NAST) may draw advantages from the nodal downstaging effect and reduce the extent of axillary surgery with sentinel lymph node biopsy (SLNB) perfor
Publikováno v:
Breast Cancer Research and Treatment
Purpose The timing of sentinel lymph node biopsy (SLNB) in the context of neoadjuvant systemic therapy (NAST) in breast cancer is still controversial. SLNB before NAST has been evaluated in few single-institution studies in which axillary lymph node
Publikováno v:
British Journal of Surgery. 104:238-247
Background The omission of axillary lymph node dissection (ALND) in patients with breast cancer with a negative finding on sentinel node biopsy (SNB) has reduced arm morbidity substantially. Early follow-up reports have shown the rate of axillary rec
Publikováno v:
Breast Cancer Research and Treatment
Purpose: Increasing evidence suggests that completion axillary lymph node dissection (ALND) may be omitted in breast cancer patients with limited axillary nodal metastases. However, the representativeness of trial participants for the original clinic